MedPath

Effect granulocyte colony stimulation factor (GCSF) versus placebo on implantation among infertile patients who underwent assisted reproductive technology (ART)

Phase 2
Conditions
Infertility.
Female infertility
Registration Number
IRCT201501049014N52
Lead Sponsor
Vice-chancellor for Research the Technology, Hamadan University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
Female
Target Recruitment
30
Inclusion Criteria

(a) Infertile; (b) age of 20 to 40 years; (c) having determined factor such as endometriosis, myoma, or Asherman's syndrome.
Exclusion criteria: (a) having cycle cell anemia, renal failure, upper or lower respiratory infection, or malignancy; (b) contraindication for pregnancy; (c) weak response rate.

Exclusion Criteria

Not provided

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Diagnosis of gestational sac and observation of embryo. Timepoint: 24 days after embryo transfer. Method of measurement: by transvaginal ultrasonography.
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath